Title: [Simultaneous determination of five active components in resina draconis and its extract by HPLC].
Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20120401
Title: Simultaneous quantification of loureirin A and loureirin B in rat urine, feces, and bile by HPLC-MS/MS method and its application to excretion study.
Journal: Analytical and bioanalytical chemistry 20110501
Title: Production of dragon's blood in Dracaena cochinchinensis plants by inoculation of Fusarium proliferatum.
Journal: Plant science : an international journal of experimental plant biology 20110201
Title: A sensitive LC-MS/MS method to quantify loureirin B in rat plasma with application to preclinical pharmacokinetic studies.
Journal: Journal of pharmaceutical and biomedical analysis 20091205
Title: Slow rise of intracellular Ca(2+) concentration in rat primary sensory neurons triggered by loureirin B.
Journal: Sheng li xue bao : [Acta physiologica Sinica] 20090425
Title: Material basis for inhibition of Dragon's Blood on evoked discharges of wide dynamic range neurons in spinal dorsal horn of rats.
Journal: Science in China. Series C, Life sciences 20081101
Title: Modulation of dragon's blood on tetrodotoxin-resistant sodium currents in dorsal root ganglion neurons and identification of its material basis for efficacy.
Journal: Science in China. Series C, Life sciences 20060601
Title: Sha Y, et al. Loureirin B promotes insulin secretion through inhibition of KATP channel and influx of intracellular calcium. J Cell Biochem. 2017 Aug 17.
Title: He T, et al. Loureirin B Inhibits Hypertrophic Scar Formation via Inhibition of the TGF-β1-ERK/JNK Pathway. Cell Physiol Biochem. 2015;37(2):666-76.
Title: Bai X, et al. Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway. Exp Dermatol. 2015 May;24(5):355-60.
Title: Yu Jiang, et al. Bioactivity-Guided Fractionation of the Traditional Chinese Medicine Resina Draconis Reveals Loureirin B as a PAI-1 Inhibitor. Evidence-Based Complementary and Alternative Medicine
